Physician
Ceretto, Vincent
Ceretto, Vincent was paid $188K by Medicaid between May 2022 and Nov 2024, across 7 billing codes. Its largest line is G9012, Other specified case management service not elsewhere classified — 70% of everything it billed.
33Billing provider infoCERETTO, VINCENT
PITTSBURGH, PA 15212
PITTSBURGH, PA 15212
33aNPI1003262999assigned 05/10/2016
33bProvider typeMedical Toxicology (Emergency Medicine) Physician
28Total paid$188K
24GClaims1,939
24DCodes billed7
24AFirst – last monthMay 2022 – Nov 2024
Compared with peers
Next to other Medical Toxicology (Emergency Medicine) Physician providers in Pennsylvania
Rank by total paid#3 of 9
Median peer was paid$67K
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 50 | $2K | |
| 2023 | 614 | $70K | |
| 2024incomplete | 1,275 | $116K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9012 | Other specified case management service not elsewhere classified | 70% | 463 | 461 | $131K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 441 | 391 | $23K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.0% | 356 | 332 | $13K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.4% | 124 | 118 | $8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 3.5% | 145 | 142 | $7K |
| 80305 | 2.3% | 360 | 338 | $4K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | <1% | 50 | 50 | $2K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.